Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q1 2021 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2021-05-17

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (20)

CGEM Cullinan Oncology, Inc. 33.5%

Value $114M Shares 2,731,410 Est. Cost $40.60 Unrealized 0.0%

— Gemini Therapeutics, Inc. 9.7%

Value $33M Shares 2,435,125 Est. Cost $13.55 Unrealized —

ACRS Aclaris Therapeutics, Inc. 9.3%

Value $31.71M Shares 1,258,243 Est. Cost $19.56 Unrealized 0.0%

— Kinnate Biopharma Inc. 8.0%

Value $27.27M Shares 875,001 Est. Cost $39.78 Unrealized —

ALXO ALX Oncology Holdings Inc. 6.9%

Value $23.6M Shares 320,000 Est. Cost $60.15 Unrealized +30.8%

PHVS Pharvaris N.V. 5.5%

Value $18.58M Shares 664,142 Est. Cost $31.46 Unrealized 0.0%

NRIX Nurix Therapeutics, Inc. 4.1%

Value $14.04M Shares 451,522 Est. Cost $33.14 Unrealized +14.2%

HIMS Hims & Hers Health, Inc. 4.1%

Value $13.98M Shares 1,056,922 Est. Cost $16.76 Unrealized 0.0%

RLAY Relay Therapeutics, Inc. 4.1%

Value $13.83M Shares 400,000 Est. Cost $45.21 Unrealized -4.0%

— Population Health Investment Co., Inc. 2.8%

Value $9.648M Shares 960,000 Est. Cost $10.45 Unrealized —

— Olink Holding AB 2.1%

Value $7.2M Shares 200,000 Est. Cost $36.00 Unrealized —

— FS Development Corp. II 1.8%

Value $6.001M Shares 602,500 Est. Cost $9.96 Unrealized —

— Lucira Health, Inc. 1.7%

Value $5.869M Shares 485,000 Est. Cost $12.10 Unrealized —

— Research Alliance Corp. II 1.5%

Value $5.125M Shares 500,000 Est. Cost $10.25 Unrealized —

— BCTG Acquisition Corp. 1.3%

Value $4.448M Shares 400,000 Est. Cost $11.44 Unrealized —

— LifeSci Acquisition II Corp. 1.2%

Value $4.056M Shares 400,000 Est. Cost $10.67 Unrealized —

— Therapeutics Acquisition Corp 1.1%

Value $3.679M Shares 350,000 Est. Cost $13.92 Unrealized —

MLTX Helix Acquisition Corp. 0.7%

Value $2.55M Shares 250,000 Est. Cost $11.37 Unrealized —

— Consonance-HFW Acquisition Corp. 0.3%

Value $976K Shares 100,000 Est. Cost $10.47 Unrealized —

IMVT Immunovant, Inc. 0.2%

Value $802K Shares 50,000 Est. Cost $26.37 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	2,731,410	$114M	33.5%	$40.60	0.0%	COM	230031106
—	Gemini Therapeutics, Inc.	2,435,125	$33M	9.7%	$13.55	—	COM	36870G105
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$31.71M	9.3%	$19.56	0.0%	COM	00461U105
—	Kinnate Biopharma Inc.	875,001	$27.27M	8.0%	$39.78	—	COM	49705R105
ALXO	ALX Oncology Holdings Inc.	320,000	$23.6M	6.9%	$60.15	+30.8%	COM	00166B105
PHVS	Pharvaris N.V.	664,142	$18.58M	5.5%	$31.46	0.0%	COM	N69605108
NRIX	Nurix Therapeutics, Inc.	451,522	$14.04M	4.1%	$33.14	+14.2%	COM	67080M103
HIMS	Hims & Hers Health, Inc.	1,056,922	$13.98M	4.1%	$16.76	0.0%	COM CL A	433000106
RLAY	Relay Therapeutics, Inc.	400,000	$13.83M	4.1%	$45.21	-4.0%	COM	75943R102
—	Population Health Investment Co., Inc.	960,000	$9.648M	2.8%	$10.45	—	UNIT	G71716123
—	Olink Holding AB	200,000	$7.2M	2.1%	$36.00	—	SPONSORED ADS	680710100
—	FS Development Corp. II	602,500	$6.001M	1.8%	$9.96	—	COM CL A	30318F100
—	Lucira Health, Inc.	485,000	$5.869M	1.7%	$12.10	—	COM	54948U105
—	Research Alliance Corp. II	500,000	$5.125M	1.5%	$10.25	—	COM CL A	760873109
—	BCTG Acquisition Corp.	400,000	$4.448M	1.3%	$11.44	—	COM	05492W103
—	LifeSci Acquisition II Corp.	400,000	$4.056M	1.2%	$10.67	—	COM	53229E103
—	Therapeutics Acquisition Corp	350,000	$3.679M	1.1%	$13.92	—	COM CL A	88339T103
MLTX	Helix Acquisition Corp.	250,000	$2.55M	0.7%	$11.37	—	COM CL A	G4444C102
—	Consonance-HFW Acquisition Corp.	100,000	$976K	0.3%	$10.47	—	UNIT	0G244M129
IMVT	Immunovant, Inc.	50,000	$802K	0.2%	$26.37	0.0%	COM	45258J102